Tuesday, 02 January 2024 12:17 GMT

Gainey Mckenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Carmax, Inc., (KMX)


(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Maryland on behalf of all persons or entities who purchased or otherwise acquired CarMax, Inc. (“CarMax” or the“Company”) (NYSE: KMX) securities between June 20, 2025 and September 24, 2025, inclusive (the“Class Period”).

The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that (1) Defendants recklessly overstated CarMax's growth prospects when, in reality, its earlier growth in the 2026 fiscal year was a temporary benefit from customers buying cars due to speculation regarding tariffs and (2) as a result, Defendants' statements about CarMax's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Investors who purchased or otherwise acquired shares of CarMax should contact the Firm prior to the June 2, 2026 lead plaintiff motion deadline. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at ... or ....

Please visit our website at for more information about the firm.


MENAFN04112025004107003653ID1110294182



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search